108 related articles for article (PubMed ID: 6389648)
1. Further evaluation of local intranasal immunotherapy with aqueous and allergoid grass extracts.
Georgitis JW; Clayton WF; Wypych JI; Barde SH; Reisman RE
J Allergy Clin Immunol; 1984 Nov; 74(5):694-700. PubMed ID: 6389648
[TBL] [Abstract][Full Text] [Related]
2. Local intranasal immunotherapy for grass-allergic rhinitis.
Georgitis JW; Reisman RE; Clayton WF; Mueller UR; Wypych JI; Arbesman CE
J Allergy Clin Immunol; 1983 Jan; 71(1 Pt 1):71-6. PubMed ID: 6337198
[TBL] [Abstract][Full Text] [Related]
3. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O
Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
[TBL] [Abstract][Full Text] [Related]
4. Decrease of allergen-specific T-cell response induced by local nasal immunotherapy.
Giannarini L; Maggi E
Clin Exp Allergy; 1998 Apr; 28(4):404-12. PubMed ID: 9641566
[TBL] [Abstract][Full Text] [Related]
5. Controlled evaluation of allergoid in the immunotherapy of ragweed hay fever.
Norman PS; Lichtenstein LM; Kagey-Sobotka A; Marsh DG
J Allergy Clin Immunol; 1982 Oct; 70(4):248-60. PubMed ID: 6181113
[TBL] [Abstract][Full Text] [Related]
6. Local intranasal immunotherapy with high-dose polymerized ragweed extract.
Georgitis JW; Nickelsen JA; Wypych JI; Barde SH; Clayton WF; Reisman RE
Int Arch Allergy Appl Immunol; 1986; 81(2):170-3. PubMed ID: 3759259
[TBL] [Abstract][Full Text] [Related]
7. Local nasal immunotherapy for birch allergic rhinitis with extract in powder form.
Andri L; Senna G; Andri G; Dama A; Givanni S; Betteli C; Dimitri G; Falagiani P; Mezzelani P
Clin Exp Allergy; 1995 Nov; 25(11):1092-9. PubMed ID: 8581842
[TBL] [Abstract][Full Text] [Related]
8. Local intranasal immunotherapy for ragweed allergic rhinitis. II. Immunologic response.
Nickelsen JA; Goldstein S; Mueller U; Wypych J; Reisman RE; Arbesman CE
J Allergy Clin Immunol; 1981 Jul; 68(1):41-5. PubMed ID: 6972401
[TBL] [Abstract][Full Text] [Related]
9. Clinical efficacy and tolerability of a steady dosage schedule of local nasal immunotherapy. Results of preseasonal treatment in grass pollen rhinitis.
Bertoni M; Cosmi F; Bianchi I; Di Berardino L
Ann Allergy Asthma Immunol; 1999 Jan; 82(1):47-51. PubMed ID: 9988206
[TBL] [Abstract][Full Text] [Related]
10. Short-term preseasonal immunotherapy: is early clinical efficacy related to the basophil response?
Kepil Özdemir S; Sin BA; Güloğlu D; İkincioğulları A; Gençtürk Z; Mısırlıgil Z
Int Arch Allergy Immunol; 2014; 164(3):237-45. PubMed ID: 25170594
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of preseasonal-specific immunotherapy with an aluminium-adsorbed six-grass pollen allergoid.
Corrigan CJ; Kettner J; Doemer C; Cromwell O; Narkus A;
Allergy; 2005 Jun; 60(6):801-7. PubMed ID: 15876311
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of sublingual coseasonal immunotherapy with a monomeric allergoid in Cupressaceae pollen allergy--preliminary data.
Ariano R; Panzani RC; Mistrello G
Eur Ann Allergy Clin Immunol; 2005 Mar; 37(3):103-8. PubMed ID: 15918297
[TBL] [Abstract][Full Text] [Related]
13. Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. II. Comparison between parameters assessing the efficacy of immunotherapy.
Bousquet J; Maasch H; Martinot B; Hejjaoui A; Wahl R; Michel FB
J Allergy Clin Immunol; 1988 Sep; 82(3 Pt 1):439-46. PubMed ID: 3170992
[TBL] [Abstract][Full Text] [Related]
14. Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. I. Rush immunotherapy with allergoids and standardized orchard grass-pollen extract.
Bousquet J; Hejjaoui A; Skassa-Brociek W; Guérin B; Maasch HJ; Dhivert H; Michel FB
J Allergy Clin Immunol; 1987 Oct; 80(4):591-8. PubMed ID: 3668124
[TBL] [Abstract][Full Text] [Related]
15. Specific IgE response before and after rush immunotherapy with a standardized allergen or allergoid in grass pollen allergy.
Bousquet J; Braquemond P; Feinberg J; Guerin B; Maasch H; Michel FB
Ann Allergy; 1986 Jun; 56(6):456-9. PubMed ID: 3717711
[TBL] [Abstract][Full Text] [Related]
16. A double-blind, placebo-controlled trial of local nasal immunotherapy in allergic rhinitis to Parietaria pollen.
D'Amato G; Lobefalo G; Liccardi G; Cazzola M
Clin Exp Allergy; 1995 Feb; 25(2):141-8. PubMed ID: 7750006
[TBL] [Abstract][Full Text] [Related]
17. Double-blind, placebo-controlled immunotherapy with a high-molecular-weight, formalinized allergoid in grass pollen allergy.
Bousquet J; Frank E; Soussana M; Hejjaoui A; Maasch HJ; Michel FB
Int Arch Allergy Appl Immunol; 1987; 82(3-4):550-2. PubMed ID: 3553031
[TBL] [Abstract][Full Text] [Related]
18. Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. IV. Comparison of the safety and efficacy of two dosages of a high-molecular-weight allergoid.
Bousquet J; Hejjaoui A; Soussana M; Michel FB
J Allergy Clin Immunol; 1990 Feb; 85(2):490-7. PubMed ID: 2406327
[TBL] [Abstract][Full Text] [Related]
19. Local intranasal immunotherapy for ragweed allergic rhinitis. I. Clinical response.
Nickelsen JA; Goldstein S; Mueller U; Wypych J; Reisman RE; Arbesman CE
J Allergy Clin Immunol; 1981 Jul; 68(1):33-40. PubMed ID: 7240598
[TBL] [Abstract][Full Text] [Related]
20. Immunologic effect and tolerability of intra-seasonal subcutaneous immunotherapy with an 8-day up-dosing schedule to 10,000 standardized quality-units: a double-blind, randomized, placebo-controlled trial.
Pfaar O; Wolf H; Klimek L; Schnitker J; Wüstenberg E
Clin Ther; 2012 Oct; 34(10):2072-81. PubMed ID: 23063373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
